<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29739866</article-id>
<article-id pub-id-type="pmc">5990980</article-id>
<article-id pub-id-type="publisher-id">0055-18</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.0055-18.2018</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Articles</subject>
<subj-group>
<subject>Cellular/Molecular</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D<sub>2</sub> Autoreceptors Shapes the <italic>In Vivo</italic> Impact of the Neuropsychiatric Disease-Associated DAT Variant Val559</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-2477-8648</contrib-id>
<name>
<surname>Gowrishankar</surname>
<given-names>Raajaram</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-7020-010X</contrib-id>
<name>
<surname>Gresch</surname>
<given-names>Paul J.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Davis</surname>
<given-names>Gwynne L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-2569-8236</contrib-id>
<name>
<surname>Katamish</surname>
<given-names>Rania M.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Riele</surname>
<given-names>Justin R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stewart</surname>
<given-names>Adele M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vaughan</surname>
<given-names>Roxanne A.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hahn</surname>
<given-names>Maureen K.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0002-2182-6966</contrib-id>
<name>
<surname>Blakely</surname>
<given-names>Randy D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, </aff>
<aff id="aff2"><sup>2</sup>Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota 58201, </aff>
<aff id="aff3"><sup>3</sup>Department of Biomedical Science, Charles E. Schmidt College of Medicine, and </aff>
<aff id="aff4"><sup>4</sup>Brain Institute, Florida Atlantic University, Jupiter, Florida 33458</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Dr. Randy D. Blakely,
<addr-line>Florida Atlantic University, FAU Brain Institute, Room 109 MC-17, 5353 Parkside Drive, Jupiter, FL 33458.</addr-line><email>rblakely@fau.edu</email></corresp>
<fn fn-type="con">
<p>Author contributions: R.G. wrote the first draft of the paper; R.G., P.J.G., G.L.D., R.M.K., A.M.S., J.R.R., R.A.V., M.K.H., and R.D.B. edited the paper; R.G., P.J.G., G.L.D., R.M.K., A.M.S., J.R.R., R.A.V., M.K.H., and R.D.B. designed research; R.G., P.J.G., G.L.D., R.M.K., A.M.S., and J.R.R. performed research; R.A.V. contributed unpublished reagents/analytic tools; R.G., P.J.G., G.L.D., R.M.K., A.M.S., J.R.R., M.K.H., and R.D.B. analyzed data; R.G. and R.D.B. wrote the paper.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>6</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>6</day>
<month>12</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>38</volume>
<issue>23</issue>
<fpage>5302</fpage>
<lpage>5312</lpage>
<history>
<date date-type="received">
<day>9</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>4</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2018 the authors 0270-6474/18/385303-11$15.00/0</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="zns02318005302.pdf"></self-uri>
<abstract>
<p>Disruptions of dopamine (DA) signaling contribute to a broad spectrum of neuropsychiatric disorders, including attention-deficit hyperactivity disorder (ADHD), addiction, bipolar disorder, and schizophrenia. Despite evidence that risk for these disorders derives from heritable variation in DA-linked genes, a better understanding is needed of the molecular and circuit context through which gene variation drives distinct disease traits. Previously, we identified the DA transporter (DAT) variant Val559 in subjects with ADHD and established that the mutation supports anomalous DAT-mediated DA efflux (ADE). Here, we demonstrate that region-specific contributions of D<sub>2</sub> autoreceptors (D2AR) to presynaptic DA homeostasis dictate the consequences of Val559 expression in adolescent male mice. We show that activation of D2ARs in the WT dorsal striatum (DS), but not ventral striatum (VS), increases DAT phosphorylation and surface trafficking. In contrast, the activity of tyrosine hydroxylase (TH) is D2AR-dependent in both regions. In the DS but not VS of Val559 mice, tonic activation of D2ARs drives a positive feedback loop that promotes surface expression of efflux-prone DATs, raising extracellular DA levels and overwhelming DAT-mediated DA clearance capacity. Whereas D2ARs that regulate DAT are tonically activated in the Val559 DS, D2ARs that regulate TH become desensitized, allowing maintenance of cytosolic DA needed to sustain ADE. Together with prior findings, our results argue for distinct D2AR pools that regulate DA synthesis versus DA release and inactivation and offer a clear example of how the penetrance of gene variation can be limited to a subset of expression sites based on differences in intersecting regulatory networks.</p>
<p><bold>SIGNIFICANCE STATEMENT</bold> Altered dopamine (DA) signaling has been linked to multiple neuropsychiatric disorders. In an effort to understand and model disease-associated DAergic disturbances, we previously screened the DA transporter (DAT) in subjects with attention-deficit hyperactivity disorder (ADHD) and identified multiple, functionally impactful, coding variants. One of these variants, Val559, supports anomalous DA efflux (ADE) and in transgenic mice leads to changes in locomotor patterns, psychostimulant sensitivity, and impulsivity. Here, we show that the penetrance of Val559 ADE is dictated by region-specific differences in how presynaptic D<sub>2</sub>-type autoreceptors (D2ARs) constrain DA signaling, biasing phenotypic effects to dorsal striatal projections. The Val559 model illustrates how the impact of genetic variation underlying neuropsychiatric disorders can be shaped by the differential engagement of synaptic regulatory mechanisms.</p>
</abstract>
<kwd-group>
<kwd>dopamine</kwd>
<kwd>dopamine D<sub>2</sub> autoreceptor</kwd>
<kwd>dopamine transporter</kwd>
<kwd>neuropsychiatric disorders</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>